Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
2.225
-0.075 (-3.26%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Artiva Biotherapeutics Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$20.00
Upside
+798.88%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +933.71% | Apr 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +798.88% | Mar 26, 2025 |
| Wedbush | Wedbush | Buy Reiterates $18 | Buy | Reiterates | $18 | +708.99% | Mar 25, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $23 → $20 | Buy | Maintains | $23 → $20 | +798.88% | Mar 25, 2025 |
| Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +933.71% | Mar 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +798.88% | Dec 30, 2024 |
| Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +933.71% | Nov 13, 2024 |
| Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +933.71% | Aug 30, 2024 |
| Needham | Needham | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +933.71% | Aug 13, 2024 |
| Wedbush | Wedbush | Buy Initiates $18 | Buy | Initiates | $18 | +708.99% | Aug 13, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $23 | Buy | Initiates | $23 | +933.71% | Aug 13, 2024 |
| TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Aug 13, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $21 | Strong Buy | Initiates | $21 | +843.82% | Aug 13, 2024 |